Weighted Average Number of Shares Outstanding, Basic of Cerevel Therapeutics Holdings, Inc. from 31 Dec 2020 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2020 to 31 Mar 2024.
  • Cerevel Therapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Mar 2024 was 181,610,675, a 16% increase year-over-year.
  • Cerevel Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 162,056,405, a 7.1% increase from 2022.
  • Cerevel Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 151,265,635, a 11% increase from 2021.
  • Cerevel Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 136,576,536, a 85% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Cerevel Therapeutics Holdings, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 181,610,675 +24,962,310 +16% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 162,056,405 +10,790,770 +7.1% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2024 2023 FY
Q3 2023 157,498,891 +5,194,246 +3.4% 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 157,050,677 +8,754,961 +5.9% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 156,648,365 +8,663,439 +5.9% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 151,265,635 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 152,304,645 +8,282,536 +5.8% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 148,295,716 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 147,984,926 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q3 2021 144,022,109 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3

Cerevel Therapeutics Holdings, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 162,056,405 +10,790,770 +7.1% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2024 2023 FY
2022 151,265,635 +14,689,099 +11% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
2021 136,576,536 +62,933,221 +85% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 73,643,315 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.